PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $38,000 | -71.2% | 44,974 | -66.7% | 0.00% | – |
| Q2 2019 | $132,000 | -22.8% | 134,904 | -0.4% | 0.00% | – |
| Q1 2019 | $171,000 | -95.1% | 135,458 | -87.3% | 0.00% | -100.0% |
| Q4 2018 | $3,464,000 | +962.6% | 1,069,020 | +690.8% | 0.00% | – |
| Q3 2018 | $326,000 | -13.5% | 135,179 | +0.1% | 0.00% | – |
| Q2 2018 | $377,000 | -89.7% | 135,079 | -82.4% | 0.00% | -100.0% |
| Q1 2018 | $3,652,000 | +294.0% | 768,804 | +383.8% | 0.00% | – |
| Q4 2017 | $927,000 | +177.5% | 158,924 | 0.0% | 0.00% | – |
| Q3 2017 | $334,000 | -89.8% | 158,924 | -77.3% | 0.00% | -100.0% |
| Q2 2017 | $3,271,000 | -55.5% | 698,924 | -25.7% | 0.00% | 0.0% |
| Q1 2017 | $7,356,000 | +181.9% | 940,689 | +342.0% | 0.00% | 0.0% |
| Q4 2016 | $2,609,000 | -22.0% | 212,817 | -0.9% | 0.00% | 0.0% |
| Q3 2016 | $3,347,000 | – | 214,717 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|